

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 8.25230978 |
| 2 | negative regulation of neurotransmitter secretion (GO:0046929) | 6.92099017 |
| 3 | nerve growth factor signaling pathway (GO:0038180) | 6.56803715 |
| 4 | negative regulation of neurotransmitter transport (GO:0051589) | 5.94865298 |
| 5 | protein neddylation (GO:0045116) | 5.91681794 |
| 6 | positive regulation of vasculogenesis (GO:2001214) | 5.75902579 |
| 7 | Rap protein signal transduction (GO:0032486) | 5.08961630 |
| 8 | purine nucleobase biosynthetic process (GO:0009113) | 4.73153899 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 4.65195162 |
| 10 | nucleobase biosynthetic process (GO:0046112) | 4.53864745 |
| 11 | proteasome assembly (GO:0043248) | 4.39170588 |
| 12 | negative regulation of norepinephrine secretion (GO:0010700) | 4.38827356 |
| 13 | regulation of establishment of cell polarity (GO:2000114) | 4.27929647 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 4.26431337 |
| 15 | DNA replication checkpoint (GO:0000076) | 4.19458834 |
| 16 | DNA replication initiation (GO:0006270) | 4.16711125 |
| 17 | DNA deamination (GO:0045006) | 4.13191539 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 4.12365126 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.12365126 |
| 20 | ribosome biogenesis (GO:0042254) | 4.10900686 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.09021748 |
| 22 | formation of translation preinitiation complex (GO:0001731) | 4.06209964 |
| 23 | response to pheromone (GO:0019236) | 4.03723397 |
| 24 | 7-methylguanosine mRNA capping (GO:0006370) | 4.03434386 |
| 25 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.03151841 |
| 26 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.02176013 |
| 27 | 7-methylguanosine RNA capping (GO:0009452) | 3.99776514 |
| 28 | RNA capping (GO:0036260) | 3.99776514 |
| 29 | mitotic metaphase plate congression (GO:0007080) | 3.98435346 |
| 30 | ribosomal large subunit biogenesis (GO:0042273) | 3.96968487 |
| 31 | CENP-A containing nucleosome assembly (GO:0034080) | 3.95470505 |
| 32 | positive regulation of granulocyte differentiation (GO:0030854) | 3.95249297 |
| 33 | ribosomal small subunit biogenesis (GO:0042274) | 3.93862109 |
| 34 | DNA strand elongation (GO:0022616) | 3.89829139 |
| 35 | regulation of vasculogenesis (GO:2001212) | 3.86409989 |
| 36 | response to nerve growth factor (GO:1990089) | 3.83926185 |
| 37 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.83926185 |
| 38 | spliceosomal snRNP assembly (GO:0000387) | 3.82216759 |
| 39 | chromatin remodeling at centromere (GO:0031055) | 3.81644343 |
| 40 | * rRNA modification (GO:0000154) | 3.80414499 |
| 41 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.76016747 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.74702590 |
| 43 | * rRNA processing (GO:0006364) | 3.74192986 |
| 44 | thrombin receptor signaling pathway (GO:0070493) | 3.74091317 |
| 45 | viral mRNA export from host cell nucleus (GO:0046784) | 3.73120167 |
| 46 | translational termination (GO:0006415) | 3.64542286 |
| 47 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.64350134 |
| 48 | termination of RNA polymerase I transcription (GO:0006363) | 3.62891167 |
| 49 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.62868414 |
| 50 | telomere maintenance via recombination (GO:0000722) | 3.62643169 |
| 51 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.62469949 |
| 52 | cullin deneddylation (GO:0010388) | 3.61102992 |
| 53 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.60977327 |
| 54 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.60668850 |
| 55 | viral transcription (GO:0019083) | 3.60589707 |
| 56 | * rRNA metabolic process (GO:0016072) | 3.60537650 |
| 57 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.59788828 |
| 58 | establishment of integrated proviral latency (GO:0075713) | 3.57806002 |
| 59 | ribosome assembly (GO:0042255) | 3.51234727 |
| 60 | cellular component biogenesis (GO:0044085) | 3.50075848 |
| 61 | protein deneddylation (GO:0000338) | 3.47631548 |
| 62 | pseudouridine synthesis (GO:0001522) | 3.46034826 |
| 63 | DNA replication-independent nucleosome organization (GO:0034724) | 3.45268811 |
| 64 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.45268811 |
| 65 | metaphase plate congression (GO:0051310) | 3.44099351 |
| 66 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.43892256 |
| 67 | negative regulation of ligase activity (GO:0051352) | 3.43892256 |
| 68 | transcription from RNA polymerase I promoter (GO:0006360) | 3.41778256 |
| 69 | spliceosomal complex assembly (GO:0000245) | 3.39952239 |
| 70 | mitotic recombination (GO:0006312) | 3.39545582 |
| 71 | maturation of 5.8S rRNA (GO:0000460) | 3.38548859 |
| 72 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.38218320 |
| 73 | kinetochore organization (GO:0051383) | 3.38040330 |
| 74 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.37053118 |
| 75 | translational initiation (GO:0006413) | 3.36584829 |
| 76 | replication fork processing (GO:0031297) | 3.34832438 |
| 77 | regulation of penile erection (GO:0060405) | 3.33447860 |
| 78 | telomere maintenance via telomere lengthening (GO:0010833) | 3.31513760 |
| 79 | kinetochore assembly (GO:0051382) | 3.31146949 |
| 80 | IMP biosynthetic process (GO:0006188) | 3.31130075 |
| 81 | definitive hemopoiesis (GO:0060216) | 3.30457729 |
| 82 | chaperone-mediated protein transport (GO:0072321) | 3.29392062 |
| 83 | regulation of mitochondrial translation (GO:0070129) | 3.27312348 |
| 84 | protein localization to kinetochore (GO:0034501) | 3.25844543 |
| 85 | relaxation of smooth muscle (GO:0044557) | 3.24514666 |
| 86 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.23260723 |
| 87 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.22969154 |
| 88 | cell cycle G1/S phase transition (GO:0044843) | 3.22969154 |
| 89 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.22676091 |
| 90 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.22017953 |
| 91 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.21079912 |
| 92 | translation (GO:0006412) | 3.20719970 |
| 93 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.20397905 |
| 94 | histone exchange (GO:0043486) | 3.20331877 |
| 95 | translational elongation (GO:0006414) | 3.20048852 |
| 96 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.18813947 |
| 97 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.18713496 |
| 98 | cotranslational protein targeting to membrane (GO:0006613) | 3.18111660 |
| 99 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.16610846 |
| 100 | negative regulation of heart rate (GO:0010459) | 3.13267529 |
| 101 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.13112732 |
| 102 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.12663865 |
| 103 | protein targeting to ER (GO:0045047) | 3.11964175 |
| 104 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.11950568 |
| 105 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.11441900 |
| 106 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.10860288 |
| 107 | DNA double-strand break processing (GO:0000729) | 3.10299831 |
| 108 | positive regulation of Rap GTPase activity (GO:0032854) | 3.10175763 |
| 109 | mitotic G2/M transition checkpoint (GO:0044818) | 3.07369539 |
| 110 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.07132452 |
| 111 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.07132452 |
| 112 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.06840313 |
| 113 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06797446 |
| 114 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06797446 |
| 115 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06797446 |
| 116 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.06498678 |
| 117 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.05846448 |
| 118 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05727925 |
| 119 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05727925 |
| 120 | IMP metabolic process (GO:0046040) | 3.05555924 |
| 121 | * rRNA methylation (GO:0031167) | 3.05427807 |
| 122 | mitotic nuclear envelope disassembly (GO:0007077) | 3.05036562 |
| 123 | DNA-templated transcription, termination (GO:0006353) | 3.04524123 |
| 124 | purine nucleotide salvage (GO:0032261) | 3.04140261 |
| 125 | positive regulation of ligase activity (GO:0051351) | 3.03836859 |
| 126 | DNA-templated transcription, elongation (GO:0006354) | 3.03477534 |
| 127 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.02451488 |
| 128 | peptidyl-histidine modification (GO:0018202) | 3.02349468 |
| 129 | cellular protein complex disassembly (GO:0043624) | 3.01566722 |
| 130 | DNA topological change (GO:0006265) | 3.01154670 |
| 131 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.00915153 |
| 132 | regulation of platelet aggregation (GO:0090330) | 2.97072258 |
| 133 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.96619481 |
| 134 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.93342632 |
| 135 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.93342632 |
| 136 | granulocyte differentiation (GO:0030851) | 2.92448454 |
| 137 | negative regulation of catecholamine secretion (GO:0033604) | 2.89610116 |
| 138 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.86473203 |
| 139 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.81803220 |
| 140 | histone mRNA metabolic process (GO:0008334) | 2.80305677 |
| 141 | negative regulation of exocytosis (GO:0045920) | 2.79337491 |
| 142 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.78255244 |
| 143 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.75523497 |
| 144 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.75523497 |
| 145 | regulation of Rap GTPase activity (GO:0032317) | 2.75168066 |
| 146 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.74718385 |
| 147 | negative regulation of sister chromatid segregation (GO:0033046) | 2.74718385 |
| 148 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.74718385 |
| 149 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.74718385 |
| 150 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.74718385 |
| 151 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.72641904 |
| 152 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.72641904 |
| 153 | DNA unwinding involved in DNA replication (GO:0006268) | 2.70827657 |
| 154 | GMP metabolic process (GO:0046037) | 2.70444998 |
| 155 | regulation of centriole replication (GO:0046599) | 2.69291570 |
| 156 | negative regulation of chromosome segregation (GO:0051985) | 2.66825142 |
| 157 | spindle checkpoint (GO:0031577) | 2.66103827 |
| 158 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.65011614 |
| 159 | purine-containing compound salvage (GO:0043101) | 2.64864897 |
| 160 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.64055238 |
| 161 | respiratory chain complex IV assembly (GO:0008535) | 2.63411793 |
| 162 | establishment of endothelial barrier (GO:0061028) | 2.62257848 |
| 163 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.62185759 |
| 164 | mitotic spindle checkpoint (GO:0071174) | 2.62027070 |
| 165 | mitochondrial RNA metabolic process (GO:0000959) | 2.61428094 |
| 166 | mitotic spindle assembly checkpoint (GO:0007094) | 2.61157965 |
| 167 | negative regulation of response to food (GO:0032096) | 2.60764391 |
| 168 | negative regulation of appetite (GO:0032099) | 2.60764391 |
| 169 | spindle assembly checkpoint (GO:0071173) | 2.59256102 |
| 170 | ether lipid metabolic process (GO:0046485) | 2.57696454 |
| 171 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.57542129 |
| 172 | DNA ligation (GO:0006266) | 2.56615811 |
| 173 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.55308674 |
| 174 | isotype switching (GO:0045190) | 2.55308674 |
| 175 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.55308674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.70318886 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.56318033 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.52725244 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.93084149 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.84635947 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.73169716 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.51470325 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.41060069 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.40850293 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.24515238 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.19641847 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.13022441 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.10625341 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.09778888 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.06859786 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 3.04191910 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.82930655 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.74354327 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.69652892 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.64003810 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.54189961 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45358886 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.43163213 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.37634906 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.36394351 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25857484 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.25110607 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24987480 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24783337 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23366035 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.21278293 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.19027694 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16233895 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15245286 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.09555246 |
| 36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.06511564 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00419079 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.98546870 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.97800547 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.95249856 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94761727 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.94725278 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93822999 |
| 44 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.92241101 |
| 45 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90394572 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87363528 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.74031848 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73457486 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.72191360 |
| 50 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.68572119 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67775600 |
| 52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.65135943 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63272313 |
| 54 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.63253393 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62493600 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60863528 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57086278 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55640839 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55405785 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54006746 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53842702 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48999011 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47643016 |
| 64 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45171420 |
| 65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.45107479 |
| 66 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.42061835 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39460597 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34054071 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31605513 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30793972 |
| 71 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.29048677 |
| 72 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27746088 |
| 73 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23820314 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.23351976 |
| 75 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.23302566 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21194685 |
| 77 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.20888700 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20336483 |
| 79 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17780713 |
| 80 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16003836 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09621895 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09432205 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06651416 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06640389 |
| 85 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05621185 |
| 86 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05185676 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04660288 |
| 88 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02571594 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01334135 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00074926 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00069299 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97354961 |
| 93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.93938973 |
| 94 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92420829 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91075754 |
| 96 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91057565 |
| 97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90532685 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90355466 |
| 99 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90042988 |
| 100 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89229960 |
| 101 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88454162 |
| 102 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.87306486 |
| 103 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87074264 |
| 104 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.86428399 |
| 105 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.86087391 |
| 106 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.85114580 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84137373 |
| 108 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.82206985 |
| 109 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.82135841 |
| 110 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82038301 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81582399 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81557900 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80970287 |
| 114 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.80189386 |
| 115 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79414487 |
| 116 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79322780 |
| 117 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.78963125 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78515715 |
| 119 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.76280152 |
| 120 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74610955 |
| 121 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.74420111 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.73954511 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73702435 |
| 124 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.73334280 |
| 125 | FUS_26573619_Chip-Seq_HEK293_Human | 0.72805861 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.72620823 |
| 127 | EWS_26573619_Chip-Seq_HEK293_Human | 0.71978546 |
| 128 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.71632469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.21602615 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.82773637 |
| 3 | MP0008057_abnormal_DNA_replication | 4.40548744 |
| 4 | MP0010094_abnormal_chromosome_stability | 4.25002364 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 4.11051493 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.87091894 |
| 7 | MP0008058_abnormal_DNA_repair | 3.73407739 |
| 8 | MP0003077_abnormal_cell_cycle | 3.56934561 |
| 9 | MP0003123_paternal_imprinting | 3.46614807 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.90560473 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.69667810 |
| 12 | MP0005084_abnormal_gallbladder_morpholo | 2.67618242 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.50787299 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.49157784 |
| 15 | MP0003786_premature_aging | 2.34945415 |
| 16 | MP0003718_maternal_effect | 2.23412384 |
| 17 | MP0001188_hyperpigmentation | 2.10748276 |
| 18 | MP0001529_abnormal_vocalization | 2.04819575 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.00410631 |
| 20 | MP0009379_abnormal_foot_pigmentation | 1.99190531 |
| 21 | MP0003763_abnormal_thymus_physiology | 1.98728650 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.87639601 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.86365314 |
| 24 | MP0003315_abnormal_perineum_morphology | 1.85827236 |
| 25 | MP0003121_genomic_imprinting | 1.85096077 |
| 26 | MP0001730_embryonic_growth_arrest | 1.79248413 |
| 27 | MP0000350_abnormal_cell_proliferation | 1.74657038 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.67270354 |
| 29 | MP0002736_abnormal_nociception_after | 1.53448569 |
| 30 | MP0004147_increased_porphyrin_level | 1.48042011 |
| 31 | MP0002163_abnormal_gland_morphology | 1.40106717 |
| 32 | MP0002210_abnormal_sex_determination | 1.36627022 |
| 33 | MP0003136_yellow_coat_color | 1.35398652 |
| 34 | MP0002102_abnormal_ear_morphology | 1.30222482 |
| 35 | MP0001697_abnormal_embryo_size | 1.28174798 |
| 36 | MP0002132_abnormal_respiratory_system | 1.27909820 |
| 37 | MP0002160_abnormal_reproductive_system | 1.23185309 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.19758608 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.18603210 |
| 40 | MP0003941_abnormal_skin_development | 1.17623550 |
| 41 | MP0002080_prenatal_lethality | 1.15392529 |
| 42 | MP0002398_abnormal_bone_marrow | 1.15211954 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.14019516 |
| 44 | MP0002938_white_spotting | 1.13405717 |
| 45 | MP0009384_cardiac_valve_regurgitation | 1.13267652 |
| 46 | MP0001905_abnormal_dopamine_level | 1.13245125 |
| 47 | MP0003880_abnormal_central_pattern | 1.12821113 |
| 48 | MP0005380_embryogenesis_phenotype | 1.12725163 |
| 49 | MP0001672_abnormal_embryogenesis/_devel | 1.12725163 |
| 50 | MP0001293_anophthalmia | 1.12478384 |
| 51 | MP0000313_abnormal_cell_death | 1.11721503 |
| 52 | MP0001145_abnormal_male_reproductive | 1.09420815 |
| 53 | MP0008872_abnormal_physiological_respon | 1.06656021 |
| 54 | MP0002085_abnormal_embryonic_tissue | 1.05639182 |
| 55 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04287553 |
| 56 | MP0003890_abnormal_embryonic-extraembry | 1.03338928 |
| 57 | MP0003787_abnormal_imprinting | 1.02402781 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.02201281 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.00573161 |
| 60 | MP0001929_abnormal_gametogenesis | 1.00513679 |
| 61 | MP0000490_abnormal_crypts_of | 0.99823422 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 0.98627349 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.98600038 |
| 64 | MP0000358_abnormal_cell_content/ | 0.96360386 |
| 65 | MP0000653_abnormal_sex_gland | 0.96089396 |
| 66 | MP0003984_embryonic_growth_retardation | 0.93778091 |
| 67 | MP0002722_abnormal_immune_system | 0.93539504 |
| 68 | MP0001968_abnormal_touch/_nociception | 0.92846883 |
| 69 | MP0004134_abnormal_chest_morphology | 0.92783025 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.92312139 |
| 71 | MP0002751_abnormal_autonomic_nervous | 0.91827544 |
| 72 | MP0008004_abnormal_stomach_pH | 0.91566336 |
| 73 | MP0001542_abnormal_bone_strength | 0.91559331 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 0.90713119 |
| 75 | MP0008260_abnormal_autophagy | 0.90233848 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.89386223 |
| 77 | MP0005409_darkened_coat_color | 0.89255416 |
| 78 | MP0002088_abnormal_embryonic_growth/wei | 0.88714661 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.87939701 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.87617510 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.87253862 |
| 82 | MP0005389_reproductive_system_phenotype | 0.86577154 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.86124189 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.84270826 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 0.84104764 |
| 86 | MP0006054_spinal_hemorrhage | 0.82379908 |
| 87 | MP0002084_abnormal_developmental_patter | 0.82185484 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.82011564 |
| 89 | MP0010307_abnormal_tumor_latency | 0.80179232 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.79782506 |
| 91 | MP0004133_heterotaxia | 0.79649132 |
| 92 | MP0010030_abnormal_orbit_morphology | 0.78822864 |
| 93 | MP0004036_abnormal_muscle_relaxation | 0.78212662 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.77834030 |
| 95 | MP0009697_abnormal_copulation | 0.77129931 |
| 96 | MP0001727_abnormal_embryo_implantation | 0.74987537 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.74717961 |
| 98 | MP0004197_abnormal_fetal_growth/weight/ | 0.74212355 |
| 99 | MP0002177_abnormal_outer_ear | 0.74057142 |
| 100 | MP0003938_abnormal_ear_development | 0.72215868 |
| 101 | MP0000566_synostosis | 0.71390470 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 0.71278623 |
| 103 | MP0004142_abnormal_muscle_tone | 0.70168383 |
| 104 | MP0003122_maternal_imprinting | 0.70124119 |
| 105 | MP0005499_abnormal_olfactory_system | 0.70041375 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.70041375 |
| 107 | MP0008770_decreased_survivor_rate | 0.69688544 |
| 108 | MP0002429_abnormal_blood_cell | 0.69330350 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.69189806 |
| 110 | MP0000049_abnormal_middle_ear | 0.69174549 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.68269379 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.68269379 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.66258781 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.65998481 |
| 115 | MP0003698_abnormal_male_reproductive | 0.65425496 |
| 116 | MP0006276_abnormal_autonomic_nervous | 0.65133403 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.64948511 |
| 118 | MP0001191_abnormal_skin_condition | 0.64260275 |
| 119 | MP0001984_abnormal_olfaction | 0.64061307 |
| 120 | MP0005266_abnormal_metabolism | 0.63785947 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.63459374 |
| 122 | MP0001119_abnormal_female_reproductive | 0.63411773 |
| 123 | MP0001286_abnormal_eye_development | 0.63259813 |
| 124 | MP0003937_abnormal_limbs/digits/tail_de | 0.63216778 |
| 125 | MP0005075_abnormal_melanosome_morpholog | 0.62737024 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.62188605 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62072803 |
| 128 | MP0005384_cellular_phenotype | 0.61726777 |
| 129 | MP0001919_abnormal_reproductive_system | 0.60807058 |
| 130 | MP0002233_abnormal_nose_morphology | 0.60640202 |
| 131 | MP0003186_abnormal_redox_activity | 0.60614256 |
| 132 | MP0001661_extended_life_span | 0.59383847 |
| 133 | MP0001186_pigmentation_phenotype | 0.58055000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.62925462 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.66795778 |
| 3 | Breast hypoplasia (HP:0003187) | 4.42134823 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.08960408 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.93824100 |
| 6 | Cerebral hypomyelination (HP:0006808) | 3.85930890 |
| 7 | Impaired platelet aggregation (HP:0003540) | 3.69244856 |
| 8 | Abnormal platelet function (HP:0011869) | 3.69244856 |
| 9 | Aplastic anemia (HP:0001915) | 3.66543200 |
| 10 | Reticulocytopenia (HP:0001896) | 3.60634709 |
| 11 | Carpal bone hypoplasia (HP:0001498) | 3.52156365 |
| 12 | Acanthocytosis (HP:0001927) | 3.44966287 |
| 13 | Increased mean platelet volume (HP:0011877) | 3.42283633 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.22671754 |
| 15 | Petechiae (HP:0000967) | 3.08500038 |
| 16 | Abnormal platelet volume (HP:0011876) | 3.05021176 |
| 17 | Patellar aplasia (HP:0006443) | 2.98133551 |
| 18 | Mitochondrial inheritance (HP:0001427) | 2.95389127 |
| 19 | Abnormality of the labia minora (HP:0012880) | 2.94743471 |
| 20 | Type 2 muscle fiber atrophy (HP:0003554) | 2.94076234 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 2.89421698 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.88456305 |
| 23 | Macrocytic anemia (HP:0001972) | 2.84532530 |
| 24 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.82138022 |
| 25 | Oral leukoplakia (HP:0002745) | 2.80414402 |
| 26 | Volvulus (HP:0002580) | 2.78677647 |
| 27 | Increased CSF lactate (HP:0002490) | 2.76621412 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.75897200 |
| 29 | Muscle fiber atrophy (HP:0100295) | 2.75633084 |
| 30 | Chromsome breakage (HP:0040012) | 2.75129537 |
| 31 | Irregular epiphyses (HP:0010582) | 2.67901986 |
| 32 | Hepatocellular necrosis (HP:0001404) | 2.67504305 |
| 33 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.65811418 |
| 34 | Colon cancer (HP:0003003) | 2.65240657 |
| 35 | Dyschromatopsia (HP:0007641) | 2.64795395 |
| 36 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.60851896 |
| 37 | Acute myeloid leukemia (HP:0004808) | 2.58594785 |
| 38 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.58297020 |
| 39 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.57862795 |
| 40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.57862795 |
| 41 | Abnormality of the preputium (HP:0100587) | 2.56992577 |
| 42 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.56435906 |
| 43 | Meckel diverticulum (HP:0002245) | 2.55495690 |
| 44 | Epistaxis (HP:0000421) | 2.55260754 |
| 45 | Pallor (HP:0000980) | 2.54642707 |
| 46 | Increased serum lactate (HP:0002151) | 2.54382760 |
| 47 | Poikilocytosis (HP:0004447) | 2.53790789 |
| 48 | Menorrhagia (HP:0000132) | 2.53288453 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.49421541 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.46869981 |
| 51 | Premature graying of hair (HP:0002216) | 2.43063967 |
| 52 | B lymphocytopenia (HP:0010976) | 2.42848579 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.42272329 |
| 54 | Abnormality of the ileum (HP:0001549) | 2.42229574 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.41516960 |
| 56 | Supernumerary spleens (HP:0009799) | 2.41076462 |
| 57 | Agnosia (HP:0010524) | 2.40766173 |
| 58 | CNS hypomyelination (HP:0003429) | 2.38637526 |
| 59 | Degeneration of anterior horn cells (HP:0002398) | 2.36588815 |
| 60 | Abnormality of the anterior horn cell (HP:0006802) | 2.36588815 |
| 61 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35896210 |
| 62 | Absent radius (HP:0003974) | 2.35730849 |
| 63 | Microretrognathia (HP:0000308) | 2.35293332 |
| 64 | Abnormality of B cell number (HP:0010975) | 2.35187698 |
| 65 | Renal cortical cysts (HP:0000803) | 2.34206721 |
| 66 | Abnormality of glycolysis (HP:0004366) | 2.34012265 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.34012265 |
| 68 | Acute encephalopathy (HP:0006846) | 2.29092242 |
| 69 | Horseshoe kidney (HP:0000085) | 2.28615994 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.26289748 |
| 71 | Adrenal hypoplasia (HP:0000835) | 2.25114906 |
| 72 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.24321201 |
| 73 | Acute lymphatic leukemia (HP:0006721) | 2.23780410 |
| 74 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.22818194 |
| 75 | Absent epiphyses (HP:0010577) | 2.22818194 |
| 76 | Abnormality of chromosome stability (HP:0003220) | 2.22685120 |
| 77 | Impulsivity (HP:0100710) | 2.22202832 |
| 78 | Aplasia involving forearm bones (HP:0009822) | 2.19048489 |
| 79 | Absent forearm bone (HP:0003953) | 2.19048489 |
| 80 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.17582719 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.17319859 |
| 82 | Abnormal lung lobation (HP:0002101) | 2.17091042 |
| 83 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.16669714 |
| 84 | Type I transferrin isoform profile (HP:0003642) | 2.14611828 |
| 85 | Severe combined immunodeficiency (HP:0004430) | 2.13458271 |
| 86 | Decreased central vision (HP:0007663) | 2.12927187 |
| 87 | Myelodysplasia (HP:0002863) | 2.10376646 |
| 88 | Conjunctival telangiectasia (HP:0000524) | 2.10304954 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.09378156 |
| 90 | Exercise intolerance (HP:0003546) | 2.07576327 |
| 91 | Selective tooth agenesis (HP:0001592) | 2.07249601 |
| 92 | Absent thumb (HP:0009777) | 2.07047577 |
| 93 | Triphalangeal thumb (HP:0001199) | 2.06583060 |
| 94 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.06554381 |
| 95 | Postnatal microcephaly (HP:0005484) | 2.06422433 |
| 96 | Bone marrow hypocellularity (HP:0005528) | 2.06051386 |
| 97 | Pancreatic fibrosis (HP:0100732) | 2.02139876 |
| 98 | Methylmalonic acidemia (HP:0002912) | 1.98917784 |
| 99 | Secondary amenorrhea (HP:0000869) | 1.98695971 |
| 100 | Glossoptosis (HP:0000162) | 1.98523315 |
| 101 | Stenosis of the external auditory canal (HP:0000402) | 1.98448812 |
| 102 | Abnormal trabecular bone morphology (HP:0100671) | 1.98318284 |
| 103 | Cerebral edema (HP:0002181) | 1.97809882 |
| 104 | Cleft eyelid (HP:0000625) | 1.97758166 |
| 105 | Multiple enchondromatosis (HP:0005701) | 1.97656608 |
| 106 | Medulloblastoma (HP:0002885) | 1.96048490 |
| 107 | Small intestinal stenosis (HP:0012848) | 1.94921260 |
| 108 | Duodenal stenosis (HP:0100867) | 1.94921260 |
| 109 | Lipid accumulation in hepatocytes (HP:0006561) | 1.94831340 |
| 110 | Exertional dyspnea (HP:0002875) | 1.93301867 |
| 111 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.92539281 |
| 112 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92378955 |
| 113 | Renal Fanconi syndrome (HP:0001994) | 1.91462632 |
| 114 | Pancytopenia (HP:0001876) | 1.91299329 |
| 115 | Papillary thyroid carcinoma (HP:0002895) | 1.90914571 |
| 116 | Sloping forehead (HP:0000340) | 1.89942056 |
| 117 | Clubbing of toes (HP:0100760) | 1.88345624 |
| 118 | Hepatic necrosis (HP:0002605) | 1.87841156 |
| 119 | Neuroblastic tumors (HP:0004376) | 1.87267709 |
| 120 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.87267709 |
| 121 | Neuroblastoma (HP:0003006) | 1.87267709 |
| 122 | Primitive neuroectodermal tumor (HP:0030065) | 1.87267709 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87087043 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 1.87087043 |
| 125 | Hyperalaninemia (HP:0003348) | 1.87087043 |
| 126 | Abnormal spermatogenesis (HP:0008669) | 1.85727289 |
| 127 | Embryonal renal neoplasm (HP:0011794) | 1.85471555 |
| 128 | Pancreatic cysts (HP:0001737) | 1.85471148 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.83157374 |
| 130 | Duplicated collecting system (HP:0000081) | 1.83014685 |
| 131 | Combined immunodeficiency (HP:0005387) | 1.82566596 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 1.81769650 |
| 133 | Lactic acidosis (HP:0003128) | 1.81506057 |
| 134 | Submucous cleft hard palate (HP:0000176) | 1.81103287 |
| 135 | Abnormality of midbrain morphology (HP:0002418) | 1.80499059 |
| 136 | Molar tooth sign on MRI (HP:0002419) | 1.80499059 |
| 137 | Ependymoma (HP:0002888) | 1.80453376 |
| 138 | Abnormal protein glycosylation (HP:0012346) | 1.80061702 |
| 139 | Abnormal glycosylation (HP:0012345) | 1.80061702 |
| 140 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.80061702 |
| 141 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80061702 |
| 142 | Unsteady gait (HP:0002317) | 1.77655505 |
| 143 | Neoplasm of the pancreas (HP:0002894) | 1.76025973 |
| 144 | Rhabdomyosarcoma (HP:0002859) | 1.75532137 |
| 145 | Abnormal pupillary function (HP:0007686) | 1.75210328 |
| 146 | Cellular immunodeficiency (HP:0005374) | 1.75179119 |
| 147 | Abnormal number of incisors (HP:0011064) | 1.74780636 |
| 148 | Abnormality of lateral ventricle (HP:0030047) | 1.73234258 |
| 149 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71161804 |
| 150 | Facial hemangioma (HP:0000329) | 1.69118204 |
| 151 | IgG deficiency (HP:0004315) | 1.68685667 |
| 152 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.67431922 |
| 153 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.67042889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.55057757 |
| 2 | WEE1 | 4.10134500 |
| 3 | NUAK1 | 3.32601721 |
| 4 | EIF2AK1 | 3.18775130 |
| 5 | STK16 | 3.18447373 |
| 6 | CDK19 | 3.13839210 |
| 7 | SRPK1 | 3.08861941 |
| 8 | CDC7 | 2.86738035 |
| 9 | TRIM28 | 2.81968798 |
| 10 | NME2 | 2.62102105 |
| 11 | TSSK6 | 2.60757567 |
| 12 | VRK1 | 2.57246636 |
| 13 | ACVR1B | 2.54205634 |
| 14 | MKNK2 | 2.51760061 |
| 15 | MKNK1 | 2.36726446 |
| 16 | PLK4 | 2.30286686 |
| 17 | EIF2AK3 | 2.17189651 |
| 18 | CCNB1 | 2.14089159 |
| 19 | BRSK2 | 2.09249204 |
| 20 | PLK3 | 1.89221776 |
| 21 | TLK1 | 1.86340258 |
| 22 | CASK | 1.84348882 |
| 23 | VRK2 | 1.77242804 |
| 24 | TAOK3 | 1.75602460 |
| 25 | NME1 | 1.70412020 |
| 26 | PLK1 | 1.68796353 |
| 27 | TAF1 | 1.60403781 |
| 28 | STK3 | 1.56879681 |
| 29 | DYRK3 | 1.54829571 |
| 30 | STK39 | 1.49402297 |
| 31 | PNCK | 1.47021785 |
| 32 | NEK2 | 1.41887250 |
| 33 | NEK1 | 1.40931619 |
| 34 | TESK2 | 1.40897006 |
| 35 | TTK | 1.40216427 |
| 36 | BRD4 | 1.32142959 |
| 37 | CDK7 | 1.25873331 |
| 38 | ZAK | 1.20586836 |
| 39 | BRSK1 | 1.17550960 |
| 40 | CHEK2 | 1.17094814 |
| 41 | CDK6 | 1.15153899 |
| 42 | BMPR2 | 1.15034073 |
| 43 | AURKA | 1.13627139 |
| 44 | ATR | 1.13003246 |
| 45 | PBK | 1.12086508 |
| 46 | TNIK | 1.11448660 |
| 47 | AURKB | 1.10521467 |
| 48 | BMPR1B | 1.08297996 |
| 49 | DYRK2 | 1.03256519 |
| 50 | CDK8 | 1.03136678 |
| 51 | CSNK1G1 | 0.99801517 |
| 52 | PIM2 | 0.98291846 |
| 53 | BRAF | 0.97820675 |
| 54 | CSNK1G2 | 0.97214049 |
| 55 | AKT3 | 0.96667746 |
| 56 | TGFBR1 | 0.94394329 |
| 57 | MAP3K12 | 0.93391421 |
| 58 | PRKG2 | 0.93362606 |
| 59 | EIF2AK2 | 0.91650119 |
| 60 | BTK | 0.91220595 |
| 61 | RPS6KA4 | 0.88673488 |
| 62 | ERBB3 | 0.87656436 |
| 63 | WNK4 | 0.85380768 |
| 64 | PIK3CG | 0.84962785 |
| 65 | PASK | 0.77934521 |
| 66 | CHEK1 | 0.77751635 |
| 67 | MINK1 | 0.76427535 |
| 68 | PLK2 | 0.75818512 |
| 69 | WNK3 | 0.71606101 |
| 70 | BCKDK | 0.71477312 |
| 71 | MAP4K2 | 0.70939528 |
| 72 | NEK6 | 0.70561284 |
| 73 | MST4 | 0.69376179 |
| 74 | CSNK2A1 | 0.68395111 |
| 75 | CSNK2A2 | 0.66336941 |
| 76 | TAOK2 | 0.65785285 |
| 77 | BCR | 0.65178109 |
| 78 | ILK | 0.64971578 |
| 79 | PRKCI | 0.63509043 |
| 80 | RAF1 | 0.62668550 |
| 81 | RIPK4 | 0.60691457 |
| 82 | PRKCQ | 0.60445443 |
| 83 | RPS6KB2 | 0.56662682 |
| 84 | CDK3 | 0.56434816 |
| 85 | PRPF4B | 0.55866059 |
| 86 | YES1 | 0.55197290 |
| 87 | ATM | 0.53896775 |
| 88 | PINK1 | 0.52884638 |
| 89 | CDK2 | 0.52648184 |
| 90 | DAPK1 | 0.52495289 |
| 91 | LIMK1 | 0.50671043 |
| 92 | HIPK2 | 0.49778098 |
| 93 | RPS6KA5 | 0.49520402 |
| 94 | SYK | 0.48553285 |
| 95 | STK24 | 0.48184809 |
| 96 | CDK1 | 0.47471374 |
| 97 | BMX | 0.47264817 |
| 98 | ITK | 0.46851635 |
| 99 | MAP3K8 | 0.46281616 |
| 100 | ALK | 0.45757751 |
| 101 | CDK4 | 0.44691904 |
| 102 | PRKG1 | 0.44522319 |
| 103 | CDK11A | 0.44076896 |
| 104 | PAK1 | 0.44012132 |
| 105 | MYLK | 0.43248165 |
| 106 | DMPK | 0.42815491 |
| 107 | CSNK1G3 | 0.42693274 |
| 108 | MAP2K7 | 0.42315610 |
| 109 | CLK1 | 0.41384189 |
| 110 | CDK9 | 0.40833130 |
| 111 | ADRBK2 | 0.37636785 |
| 112 | MAP3K5 | 0.36807989 |
| 113 | GRK5 | 0.36428199 |
| 114 | CDK18 | 0.35290289 |
| 115 | STK4 | 0.34738023 |
| 116 | CDK14 | 0.33960117 |
| 117 | MAPK13 | 0.32196727 |
| 118 | CDK15 | 0.31272010 |
| 119 | MELK | 0.31099940 |
| 120 | ABL2 | 0.31006451 |
| 121 | GRK7 | 0.29961046 |
| 122 | TXK | 0.29338586 |
| 123 | ARAF | 0.27534839 |
| 124 | SCYL2 | 0.27509428 |
| 125 | PAK4 | 0.27326431 |
| 126 | MUSK | 0.27151846 |
| 127 | PIM1 | 0.25778828 |
| 128 | OXSR1 | 0.24876817 |
| 129 | EPHA2 | 0.24344353 |
| 130 | CSNK1E | 0.23691175 |
| 131 | TEC | 0.23244930 |
| 132 | RPS6KB1 | 0.22974879 |
| 133 | CAMKK2 | 0.21662248 |
| 134 | MAP3K4 | 0.21475519 |
| 135 | SIK3 | 0.19444786 |
| 136 | PRKCG | 0.18950772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA polymerase_Homo sapiens_hsa03020 | 4.37375727 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.18777110 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.06628757 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.96402420 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.92726369 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.91932356 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 3.16363476 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.93859245 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.91065253 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.86028564 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.78787160 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.62061679 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 2.31281996 |
| 14 | Platelet activation_Homo sapiens_hsa04611 | 2.28594226 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 2.28095670 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.11835628 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06266028 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.97648320 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.86375609 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81549765 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.76704142 |
| 22 | Purine metabolism_Homo sapiens_hsa00230 | 1.76677445 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66630528 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65610484 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61007184 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.51823086 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.42963861 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31239602 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.30090534 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20578546 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16928074 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14278140 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11274521 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07160832 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04824039 |
| 36 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.02693759 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.00523894 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96500863 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96062562 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 0.91553098 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88089846 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84996390 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84898994 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83973953 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83513231 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80810177 |
| 47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.79614865 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76736417 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74338447 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.73116626 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71654991 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71608619 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70906747 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70841549 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66095008 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65442563 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59561176 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59066284 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57298132 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55789456 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53991677 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53155636 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52067102 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51173890 |
| 65 | Alcoholism_Homo sapiens_hsa05034 | 0.47786201 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46169470 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45833635 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45729647 |
| 69 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45116072 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.42534901 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42281051 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41577009 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39857114 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.39426097 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38922887 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38767281 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.37889058 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37095777 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.36340109 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.36057110 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34329125 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33981209 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33359185 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33037912 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31098964 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30567263 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28543875 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.27352660 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26277295 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.25732316 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.24698779 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.24475017 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23775189 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23401840 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.22983439 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.22309711 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.21867117 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21213122 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.19797037 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19233153 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18587628 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.18441452 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18184054 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.18006587 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.17459118 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17302757 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.16784817 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.15523996 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.15226091 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14860227 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.14510171 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.14270278 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.13176953 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12791668 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.12650402 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12171064 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08477348 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06561531 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.06539690 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06326486 |
| 121 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.05668247 |
| 122 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.04972186 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.04801754 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.04337514 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.03924031 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.03727710 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.03686845 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.03660341 |
| 129 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03349197 |
| 130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.01121659 |
| 131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.00900714 |
| 132 | Carbon metabolism_Homo sapiens_hsa01200 | 0.00829487 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.00417008 |

